FDA approves venetoclax in 2nd-line for patients with CLL or SLL

 

Ribociclib FDA label updated to include pre- and perimenopausal women
  • Save
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply